4Hotamisligil G. Inflammation and metabolic disorders. Nature, 2006,444 (7121 ) : 860 - 867.
5Dupuy AM,Terrier N, S6n6cal L, et al. Is C - reactive protein a maker of inflammation. Nephrologie,2003,24 (7) :337 - 341.
6Fukami K, Ueda S, Yamagishi S, et al. AGEs activate mesangial TGF -beta -Samd signaling via an angiotension Ⅱ type Ⅰ receptor interaction. Kidney Int ,2004,66 (6) :2137 - 2147.
7Tesch GH. MCP - 1/CCL2 : a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol,2008,294(4) :F697 -F701.
8Chow FY, Nikolic - Paterson D J, Ozols E, et al. Monocyte chemoattractant protein - 1 promotes diabetic renal injury in streptozotocin - treated mice. Kidney Int ,2006 ,69 ( 1 ) :73 - 80.
9Moon JY,Jeong L, Lee S, et al. Association of polymorphisms in monocyte chemoattractant protein - 1 promoter with diabetic kid- ney failure in Korean patients with type 2 diabetes mellitus. J Korean Med Sci ,2007,22(5 ) :810 - 814.
10Han SY, Kim HS. Spironolactone prevent diabetic nephropathy through an anti - inflammatory mechanism in type 2 diabetic rats. J Am Soc Nephrol,2006,17 (5): 1362 - 1372.
